Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Afeyan Noubar
Relationship:   Director, 10% Owner
City:   Lexington
State:   MA
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   8,055,025    

Indirect Shares

   111,880,829      
Direct Value   $20,269,096    

Indirect Value

   $90,389,482      
Total Shares   119,935,854      
Total Value   $110,658,578      


Color Kinetics Inc $0 Receptos, Inc. $0 Editas Medicine, Inc. $20,257,348 Seres Therapeutics, Inc. $11,748 Moderna, Inc. $0 Color Kinetics Inc $0 Receptos, Inc. $0 Editas Medicine, Inc. $20,257,348 Seres Therapeutics, Inc. $11,748 Moderna, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    10   
    0    

     Stock price went up :
    3   
    0    
     Stock price went down :
    7   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   -22.5%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Color Kinetics Inc CLRK Director 2005-10-03 83,062 2005-10-03 12,000    Premium*  
            Agenus Inc AGEN Director 2006-12-14 0 2006-12-14 0    Premium*  
            Helicos Biosciences Corp HLCSQ Director, 10% Owner 2009-09-18 0 2009-09-18 12,192,640    Premium*  
            Receptos, Inc. RCPT 10% Owner 2013-11-18 1,693,551 0    Premium*  
            DNIB Upwind Inc BIND Director, 10% Owner 2013-09-25 0 2013-09-25 1,562,616    Premium*  
            Bg Medicine, Inc. BGMD Director, 10% Owner 2015-12-09 0 2015-12-09 1,286,274    Premium*  
            Editas Medicine, Inc. EDIT 10% Owner 2016-02-08 3,964,256 2016-02-08 991,060    Premium*  
            Selecta Biosciences Inc SELB 10% Owner 2016-06-27 0 2016-06-27 1,651,862    Premium*  
            Kaleido Biosciences, Inc. KLDO 10% Owner 0 2021-02-08 14,907,627    Premium*  
            Transmedics Group, Inc. TMDX 10% Owner 0 2019-10-29 120,595    Premium*  
            Seres Therapeutics, Inc. MCRB 10% Owner 2019-06-18 15,141 2022-07-05 17,617,352    Premium*  
            Moderna, Inc. MRNA 2024-06-18 2,299,015 2024-06-18 4,632,149    Premium*  
            Axcella Health Inc. AXLA 10% Owner 2020-05-18 0 2022-10-13 8,850,296    Premium*  
            Evelo Biosciences Inc EVLO 2020-06-29 0 2023-07-11 4,977,588    Premium*  
            Codiak Biosciences, Inc. CDAK 10% Owner 0 2022-09-15 1,674,869    Premium*  
            Foghorn Therapeutics Inc. FHTX 10% Owner 2020-10-27 0 2020-10-27 1,851,801    Premium*  
            Sigilon Therapeutics, Inc. SGTX 10% Owner 2020-12-08 0 2023-08-11 0    Premium*  
            Sana Biotechnology, Inc. SANA 10% Owner 2021-02-08 0 2023-09-13 581,695    Premium*  
            Rubius Therapeutics, Inc. RUBY Director, 10% Owner 2021-03-19 0 2021-03-19 17,253,519    Premium*  
            Omega Therapeutics, Inc. OMGA Director, 10% Owner 2021-08-03 0 2023-02-27 21,716,886    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
MRNA Moderna, Inc. Director   –       •      –    2021-02-22 4 AS $159.18 $301,636,406 I/I (1,836,766) 17,570,797 0 -
MRNA Moderna, Inc. Director   –       •      –    2021-02-23 4 AS $136.48 $428,433,185 I/I (2,947,638) 14,623,159 0 -
EVLO Evelo Biosciences Inc 10% Owner   –       –       •   2022-05-27 4 B $1.46 $39,999,998 I/I 27,397,259 13,698,630 1.5 %
MRNA Moderna, Inc. Director   –       •      –    2021-02-24 4 AS $144.17 $256,378,924 I/I (1,753,697) 12,869,462 0 -
HLCSQ Helicos Biosciences Corp Director   –       •       •   2009-09-18 4 B $0.00 $0 I/I 242,931 12,192,640 2.17 -
SANA Sana Biotechnology, Inc. 10% Owner   –       –       •   2021-02-08 4 A $0.00 $0 I/I 34,239,018 11,585,199 0 -
MRNA Moderna, Inc. Director   –       •      –    2021-03-29 4 AS $122.53 $203,734,064 I/I (1,635,122) 11,234,340 0 -
MRNA Moderna, Inc. Director   –       •      –    2021-03-30 4 AS $118.04 $251,366,680 I/I (2,112,795) 9,121,545 0 -
MRNA Moderna, Inc. Director   –       •      –    2021-03-31 4 AS $121.07 $591,810 I/I (4,888) 9,116,657 0 -
MRNA Moderna, Inc. Director   –       •       •   2020-05-21 4 S $65.77 $33,447,031 I/I (500,000) 6,500,766 0 -
MRNA Moderna, Inc. Director   –       •       •   2020-05-22 4 S $69.45 $34,772,245 I/I (500,000) 6,420,766 0 -
MRNA Moderna, Inc. Director   –       •      –    2022-05-12 4 AS $129.39 $26,101,175 I/I (200,000) 5,916,657 0 -
MCRB Seres Therapeutics, Inc. 10% Owner   –       –       •   2022-07-05 4 B $3.15 $27,525,465 I/I 8,738,243 5,825,495 1.5 %
MRNA Moderna, Inc. Director   –       •      –    2022-05-13 4 AS $133.11 $13,446,611 I/I (100,000) 5,816,657 0 -
AXLA Axcella Health Inc. 10% Owner   –       –       •   2022-03-16 4 B $1.91 $12,069,999 I/I 6,319,371 4,465,866 1.5 -
MCRB Seres Therapeutics, Inc. Director   –       •       •   2019-06-18 4 B $2.25 $19,999,998 I/I 8,888,888 4,444,444 2.25 -
EVLO Evelo Biosciences Inc 10% Owner   –       –       •   2021-02-02 4 B $15.00 $1,950,000 I/I 130,000 4,125,461 1.5 %
EVLO Evelo Biosciences Inc 10% Owner   –       –       •   2020-06-29 4 B $3.75 $17,499,998 I/I 4,666,666 4,079,032 1.5 %
EDIT Editas Medicine, Inc. 10% Owner   –       –       •   2016-02-08 4 A $0.00 $0 D/D 3,964,256 3,964,256 0 -
EVLO Evelo Biosciences Inc   –       –       •   2023-07-11 4 B $2.31 $12,499,999 I/I 5,411,255 3,931,685 0.01 %
AXLA Axcella Health Inc. 10% Owner   –       –       •   2022-10-13 4 B $1.64 $17,029,366 I/I 10,383,760 3,048,780 1.5 -
MCRB Seres Therapeutics, Inc. 10% Owner   –       –       •   2021-05-17 4 D $0.00 $0 I/I (295,171) 2,962,963 0 -
AXLA Axcella Health Inc. 10% Owner   –       –       •   2020-05-18 4 B $4.75 $18,050,000 I/I 3,800,000 2,886,023 1.5 -
RUBY Rubius Therapeutics, Inc. Director   –       •       •   2021-03-19 4 B $29.00 $6,090,000 I/I 210,000 2,633,703 2.25 %
MRNA Moderna, Inc. Director   –       •      –    2022-05-18 4 AS $138.38 $1,383,800 D/D (10,000) 2,567,209 0 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us